| New therapies for cardiogenic shock. | |
| | |
MedLine Citation:
|
PMID: 22322578 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Cardiogenic shock is a serious complication of acute myocardial infarction and occurs as a consequence of acute left ventricular failure and subsequent inappropriate tissue perfusion. While its incidence has been reported to be as high as 10% in the late 90ties, it has been steadily declining to currently less than 6% since the implementation of early revascularization as a class I indication in current guidelines. Despite recent advances in the treatment of cardiogenic shock, mortality is still high at approximately 50%. Current therapeutic approaches include early revascularization, fluid resuscitation, inotropic and vasopressor therapy, and mechanical circulatory support using intra-aortic balloon counterpulsation or percutaneous left ventricular assist devices. Novel treatment options such as specific inhibitors of inducible nitric oxide synthase or newer developments in mechanical circulatory support might be beneficial and should be tested in adequately powered randomized trials. However, difficulties in enrolling cardiogenic shock patients in randomized controlled trials are considerable. Until more data are available, cardiogenic shock patients should be treated aggressively with early revascularization and mechanical circulatory support to increase their probability of survival. |
| | |
Authors:
|
R V Jeger |
Related Documents
:
|
21217068 - Anthrax edema toxin has camp-mediated stimulatory effects and high-dose lethal toxin ha... 16005608 - Msct labelling for pre-operative planning in cardiac resynchronization therapy. 22037348 - Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubb... 15992638 - The coronary venous anatomy: a segmental approach to aid cardiac resynchronization ther... 16032608 - Real-time paramedic compared with blinded physician identification of st-segment elevat... 16319658 - Nature of coronary disease in patients with insulin resistance and its impact on revasc... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva cardioangiologica Volume: 60 ISSN: 0026-4725 ISO Abbreviation: Minerva Cardioangiol Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-02-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400725 Medline TA: Minerva Cardioangiol Country: Italy |
Other Details:
|
Languages: eng Pagination: 101-9 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Basel University Hospital, Basel, Switzerland - rjeger@uhbs.ch. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary interv...
Next Document: Indications, techniques and results of percutaneous patent foramen ovale closure.